M

MiCo BioMed Co Ltd
KOSDAQ:214610

Watchlist Manager
MiCo BioMed Co Ltd
KOSDAQ:214610
Watchlist
Price: 3 465 KRW -2.12% Market Closed
Market Cap: ₩29B

MiCo BioMed Co Ltd
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

MiCo BioMed Co Ltd
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
M
MiCo BioMed Co Ltd
KOSDAQ:214610
Research & Development
-₩2.9B
CAGR 3-Years
28%
CAGR 5-Years
11%
CAGR 10-Years
-6%
J
Jeisys Medical Inc
KOSDAQ:287410
Research & Development
-₩3.4B
CAGR 3-Years
-54%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Classys Inc
KOSDAQ:214150
Research & Development
-₩16.7B
CAGR 3-Years
-60%
CAGR 5-Years
-52%
CAGR 10-Years
N/A
W
Won Tech Co Ltd
KOSDAQ:336570
Research & Development
-₩1.7B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
V
Viol Co Ltd
KOSDAQ:335890
Research & Development
-₩2.9B
CAGR 3-Years
-16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Seers Technology Co Ltd
KOSDAQ:458870
Research & Development
-₩4.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

MiCo BioMed Co Ltd
Glance View

Market Cap
29B KRW
Industry
Health Care

MiCo BioMed Co. Ltd. engages in the development, manufacture and sale of in vitro diagnosis medical devices and diagnostic reagents. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2015-06-22. The firm operates its business through three segments. The Molecular Diagnosis segment mainly manufactures and sells products such as nucleic acid extraction equipment, gene amplification equipment, reagents, and lab chips. The Biochemical Diagnosis segment mainly manufactures and supplies products such as complex diagnostics, anemia meters, blood glucose meters, medical devices and strips. The Immunodiagnostic Business segment mainly produces and sells immunodiagnostic devices and immunodiagnostic kits.

Intrinsic Value
2 754.42 KRW
Overvaluation 21%
Intrinsic Value
Price
M

See Also

What is MiCo BioMed Co Ltd's Research & Development?
Research & Development
-2.9B KRW

Based on the financial report for Dec 31, 2024, MiCo BioMed Co Ltd's Research & Development amounts to -2.9B KRW.

What is MiCo BioMed Co Ltd's Research & Development growth rate?
Research & Development CAGR 10Y
-6%

Over the last year, the Research & Development growth was 21%. The average annual Research & Development growth rates for MiCo BioMed Co Ltd have been 28% over the past three years , 11% over the past five years , and -6% over the past ten years .

Back to Top